These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38545139)

  • 1. Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway.
    Luo NF; Li JL; Lv J; Chen FK; Li YN; Tang M; Liu PJ
    Heliyon; 2024 Mar; 10(6):e27840. PubMed ID: 38545139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [β-catenin nuclear translocation represses thyroid cancer stem cells differentiating into cells with sodium-iodine symporter functional expression].
    Lan L; Deng W; Cui D; Chen HL; Huo LL; Zuo QY; Li W; Zhang GY; Luo Y
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1904-1910. PubMed ID: 31269588
    [No Abstract]   [Full Text] [Related]  

  • 3. SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition
    Chen LL; Gao GX; Shen FX; Chen X; Gong XH; Wu WJ
    Mol Cells; 2018 Sep; 41(9):853-867. PubMed ID: 30165731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
    Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells.
    Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L
    PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling.
    Feng X; Jiang J; Sun L; Zhou Q
    Toxicol Appl Pharmacol; 2022 Apr; 440():115940. PubMed ID: 35219640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
    Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
    Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nuclear translocation of β-catenin represses membrane localization of NIS in human thyroid cancer cells].
    Lan L; Deng W; Chen H; Huo L; Deng L; Zhang G; Luo Y
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(11):891-6. PubMed ID: 27045654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Sitosterol blocks the LEF-1-mediated Wnt/β-catenin pathway to inhibit proliferation of human colon cancer cells.
    Gu S; Liu F; Xie X; Ding M; Wang Z; Xing X; Xiao T; Sun X
    Cell Signal; 2023 Apr; 104():110585. PubMed ID: 36603684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
    Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
    J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho Inhibits Proliferation in a RET Fusion Model of Papillary Thyroid Cancer by Regulating the Wnt/β-Catenin Pathway.
    Wu Q; Jiang L; Wu J; Dong H; Zhao Y
    Cancer Manag Res; 2021; 13():4791-4802. PubMed ID: 34168498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
    Lv P; Xue Y
    Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
    Li JY; Han C; Zheng LL; Guo MZ
    Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-449 overexpression inhibits papillary thyroid carcinoma cell growth by targeting RET kinase-β-catenin signaling pathway.
    Li Z; Huang X; Xu J; Su Q; Zhao J; Ma J
    Int J Oncol; 2016 Oct; 49(4):1629-1637. PubMed ID: 27633255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
    Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
    Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
    Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W
    Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of FHL1 suppresses papillary thyroid cancer proliferation and progression via inhibiting Wnt/β-catenin pathway.
    Chen J; Zeng C; Jin J; Zhang P; Zhang Y; Zhang H; Li Y; Guan H
    Endocrine; 2024 Jul; 85(1):238-249. PubMed ID: 38191984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
    Zhao C; Mo L; Li C; Han S; Zhao W; Liu L
    Mol Cell Endocrinol; 2020 Sep; 515():110925. PubMed ID: 32619584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-3619-3p promotes papillary thyroid carcinoma progression via Wnt/β-catenin pathway.
    Yu S; Cao S; Hong S; Lin X; Guan H; Chen S; Zhang Q; Lv W; Li Y; Xiao H
    Ann Transl Med; 2019 Nov; 7(22):643. PubMed ID: 31930044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
    Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
    PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.